PT

Dados B3 › Watcher

Watcher for ARND3: events of ARANDU INVESTIMENTOS S.A.

13 event(s) recorded for ARND3, newest first. Each is a fact with both numbers and the filing that revealed it.

Type: all · Profit or loss · Net margin changed band · Net debt/EBITDA changed band · Restated financial statements · Confidence flag changed colour

Public onTypeFact
2026-08-14Profit or lossProfit turned into loss in 2Q2026: net margin from 851.7% in 1Q2026 to -246.2% in 2Q2026.ITR 2T2026, recebida pela CVM em 14/08/2026
2026-06-23Profit or lossLoss turned into profit in 1Q2026: net margin from -34.3% in 3Q2025 to 851.7% in 1Q2026.ITR 1T2026, recebida pela CVM em 23/06/2026
2026-05-29Profit or lossProfit turned into loss in 2025: net margin from 56.0% in 2024 to -648.0% in 2025.DFP 2025, recebida pela CVM em 29/05/2026
2026-02-12Profit or lossProfit turned into loss in 1Q2025: net margin from 27.2% in 3Q2024 to -30.3% in 1Q2025.ITR 1T2025, recebida pela CVM em 12/02/2026
2024-03-29Profit or lossLoss turned into profit in 2023: net margin from -27.8% in 2022 to 6.0% in 2023.DFP 2023, recebida pela CVM em 29/03/2024
2023-08-02Profit or lossLoss turned into profit in 2Q2023: net margin from -13.2% in 1Q2023 to 9.5% in 2Q2023.ITR 2T2023, recebida pela CVM em 02/08/2023

Follow ARND3: get an e-mail when profit turns into loss, debt or margin change band, or the statements are restated. That is all, and you can cancel in one click. See every event already recorded for ARND3.

ARND3 — company page · all events · JSON · how the watcher works. Descriptive, not investment advice.

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:26 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:26 UTC. If this does not match /saude, you are reading a cached copy.